Diffuse Large B-cell Lymphoma Unclassifiable
📧 Sign up to get email alerts when something new happens for Diffuse Large B-cell Lymphoma Unclassifiable.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-08-26Clinical Trial Update: Polatuzumab Vedotin, Rituximab, Ifosfamide, Carboplatin, and Etoposide (PolaR-ICE) as Initial Salvage Therapy for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma [Phase 2]
Phase 2 study evaluating PolaR-ICE (polatuzumab vedotin, rituximab, ifosfamide, carboplatin, etoposide) as initial salvage therapy for relap…
-
CLINICAL_TRIALS trial_result · 2024-03-13Clinical Trial Update: Smart Start: A Phase II Study of Rituximab, Lenalidomide, and Ibrutinib [Phase 2]
A Phase II study of Rituximab, Lenalidomide, and Ibrutinib in Diffuse Large B-Cell Lymphoma Unclassifiable has completed with results posted…